KR830002716A - 구아니딘 화합물의 제조방법 - Google Patents

구아니딘 화합물의 제조방법

Info

Publication number
KR830002716A
KR830002716A KR1019800002130A KR800002130A KR830002716A KR 830002716 A KR830002716 A KR 830002716A KR 1019800002130 A KR1019800002130 A KR 1019800002130A KR 800002130 A KR800002130 A KR 800002130A KR 830002716 A KR830002716 A KR 830002716A
Authority
KR
South Korea
Prior art keywords
structural formula
group
compound
separable
hydrogen
Prior art date
Application number
KR1019800002130A
Other languages
English (en)
Other versions
KR840002309B1 (ko
Inventor
지. 데이브 크리스나
죠지 토마스
Original Assignee
아놀드 세일러 에른스트 알트헤르
시바 가이기 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아놀드 세일러 에른스트 알트헤르, 시바 가이기 에이지 filed Critical 아놀드 세일러 에른스트 알트헤르
Publication of KR830002716A publication Critical patent/KR830002716A/ko
Priority to KR1019840005881A priority Critical patent/KR840002310B1/ko
Application granted granted Critical
Publication of KR840002309B1 publication Critical patent/KR840002309B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

내용 없음

Description

구아니딘 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 다음 구조식(Ⅱ)의 화합물을 다음 X1, X2또는 X3에서 정의한 분리 아미노-또는 이미노 그룹에 상응하는 아민 또는 아민과 반응시키거나, 다음 구조식(Ⅳ)화합물을 다음 구조식(Ⅴ)의 화합물과 반응 시키거나 R1이 후술한 바와 같고 R2및/또는 R3가 수소인 구조식(Ⅰ)화합물을, R2및/ R3가 수소가 아니고 후술한 바와 같은 구조식(Ⅰ)의 화합물과 저급 알카놀의 반응성 에스테르 또는 특히 사이클로알카놀을 반응시켜 제조하거나, 다음 구조식(Ⅵ)생성 화합물에서 후술한 아미노 보호그룹을 분리하고, 추가 반응 단계를 진행시키고 필요시 구조식(Ⅰ)의 생성 화합물을 염으로 전환하거나, 필요시 구조식(Ⅰ) 화합물의 생성된 염을 유리염기로 전환시키는 것을 특징으로 하여 다음 구조식(Ⅰ)의 신규 구아니딘 유도체 및 그 호변 이성하합물 및 염을 제조하는 방법.
    상기 구조식에서 Ph는 치환 또는 미치환된 페닐 그룹이고, R1및 R2는 서로 다르며 각각 저급 알킬 또는 사이클로알킬 또는 R1과 R2를 합쳐서 고리의 탄소원자가 이질성 원자로 혼입되고 지방족 특성을 갖는 치환 또는 비치환된 2가 탄화 수소 래디칼이고, R3는 수소 또는 저급알킬 이고 X1은 Ph-N그룹(여기에서 Ph는 구조식(Ⅰ)에서 정의한 치환 또는 비치환된 페닐그룹)이거나 분리 가능 그룹이고 X2는 -NR1R2(여기에서 R1및 R2는 구조식(Ⅰ)에서 상술한 바와 같음)이거나 분리 가능 그룹이고 X3
    그룹(여기에서 R3는 구조식(Ⅰ)에서 상술한 바와 같음)이거나 분리 가능그룹이며 (여기에서 단 치환체 X1,X2또는 X3중 단지 1개가 분리가능 그룹일 경우 X1,X2또는 X3중 1개는 탄소원자와 이중 결합을 이룬다)
    Y는 저급알콕시 (예를 들면 메틸티오 또는 에틸티오) 할로겐 (예를들면 염소 또는 브롬)이고 또는 Y는 동일 탄소원장와 결합한 2개의 저습알콕시이고 또 Z는 테트라 플루오로보레이트 음이온, 플루오로 설포네이트 음이온, 메틸 설페이트음이온 같은 저급 알킬 설페이트 음이온 또는 메탄설포네이트 음이온등의 알칸 설포네이트 음이온 또는 염소 또는 브롬 등의 할라이드이고 또, Y가 동일 탄소상의 2개의 저급 알콕시기인 경우, 음이온으로서 Z는 존재하지 않거나 또는 R2가 수소인 경우 호변이성 형은 유리염기로서 존재하며, R2'및 R3'의 치환기중 하나는 R2또는 R3의 의미를 가지며, 다른 하나는 분리 가능한 아미노보호 그룹이다.
    ※ 참고 사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800002130A 1979-05-29 1980-05-29 구아니딘 화합물의 제조방법 KR840002309B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019840005881A KR840002310B1 (ko) 1979-05-29 1984-09-25 구아니딘 화합물의 제조방법

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH4993 1979-05-29
CH499379 1979-05-29
CH4993/79-1 1979-05-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019840005881A Division KR840002310B1 (ko) 1979-05-29 1984-09-25 구아니딘 화합물의 제조방법

Publications (2)

Publication Number Publication Date
KR830002716A true KR830002716A (ko) 1983-05-30
KR840002309B1 KR840002309B1 (ko) 1984-12-17

Family

ID=4286083

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019800002130A KR840002309B1 (ko) 1979-05-29 1980-05-29 구아니딘 화합물의 제조방법
KR1019840005881A KR840002310B1 (ko) 1979-05-29 1984-09-25 구아니딘 화합물의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019840005881A KR840002310B1 (ko) 1979-05-29 1984-09-25 구아니딘 화합물의 제조방법

Country Status (21)

Country Link
US (1) US4626537A (ko)
EP (1) EP0020303B1 (ko)
JP (1) JPS55160764A (ko)
KR (2) KR840002309B1 (ko)
AT (1) ATE15189T1 (ko)
CS (2) CS220327B2 (ko)
CY (1) CY1442A (ko)
DD (1) DD151163A5 (ko)
DE (1) DE3071029D1 (ko)
DK (1) DK156059B (ko)
ES (1) ES491926A0 (ko)
FI (1) FI75154C (ko)
GR (1) GR68377B (ko)
HK (1) HK80788A (ko)
HU (1) HU183145B (ko)
IL (1) IL60161A (ko)
NO (1) NO153850C (ko)
PL (2) PL124028B1 (ko)
PT (1) PT71313A (ko)
SG (1) SG33688G (ko)
SU (2) SU1222191A3 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8312665D0 (en) * 1983-05-09 1983-06-15 Ici Plc 4,4'-alkylenedipiperidine derivatives
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
ES2132393T3 (es) * 1993-03-23 1999-08-16 Astra Ab Derivados de guanidina utiles en terapeutica.
US6756389B2 (en) * 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US7034033B2 (en) * 2002-05-23 2006-04-25 Chiron Corporation Substituted quinazolinone compounds
AU2004249120B2 (en) * 2003-05-23 2008-07-24 Glaxosmithkline Guanidino-substituted quinazolinone compounds as MC4-R agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514584A (de) * 1967-02-27 1971-10-31 Hoffmann La Roche Verfahren zur Herstellung von Pyrrolinverbindungen
DE2205744A1 (de) * 1972-02-08 1973-08-09 Thomae Gmbh Dr K Neue durch einen guanidinylidenrest substituierte heterocyclen und verfahren zu ihrer herstellung
US3840524A (en) * 1973-04-25 1974-10-08 Richardson Merrell Inc Alpha-cycloalkylbenzyl lactamimides
US4126611A (en) * 1973-08-09 1978-11-21 Richardson-Merrell Inc. Substituted cycloalkyl lactamimides
NZ183570A (en) * 1976-03-19 1979-06-08 Mcneilab Inc Heterocyclic guanidine derivatives, having anti-secretory and hypogliycaemic activity
US4211867A (en) * 1976-03-19 1980-07-08 Mcneil Laboratories, Incorporated Nitrogen heterocyclic carboximidamide compounds
CS225804B2 (cs) * 1976-03-19 1984-02-13 Mcneilab Inc Způsob výroby heterocyklických derivátů guanidinu

Also Published As

Publication number Publication date
KR840002309B1 (ko) 1984-12-17
DK156059B (da) 1989-06-19
US4626537A (en) 1986-12-02
FI75154B (fi) 1988-01-29
IL60161A0 (en) 1980-07-31
DE3071029D1 (en) 1985-10-03
PL124028B1 (en) 1982-12-31
CS220336B2 (en) 1983-03-25
JPS55160764A (en) 1980-12-13
CY1442A (en) 1989-03-10
SU1227111A3 (ru) 1986-04-23
CS220327B2 (en) 1983-03-25
HU183145B (en) 1984-04-28
FI75154C (fi) 1988-05-09
NO153850C (no) 1986-06-04
FI801690A (fi) 1980-11-30
KR840002310B1 (ko) 1984-12-17
DK229480A (da) 1980-11-30
PL224523A1 (ko) 1981-02-13
NO801585L (no) 1980-12-01
ATE15189T1 (de) 1985-09-15
PL126790B1 (en) 1983-08-31
PT71313A (de) 1980-06-01
ES8103031A1 (es) 1981-02-16
NO153850B (no) 1986-02-24
SG33688G (en) 1989-01-27
IL60161A (en) 1984-05-31
ES491926A0 (es) 1981-02-16
DD151163A5 (de) 1981-10-08
GR68377B (ko) 1981-12-28
HK80788A (en) 1988-10-14
SU1222191A3 (ru) 1986-03-30
EP0020303A1 (de) 1980-12-10
EP0020303B1 (de) 1985-08-28

Similar Documents

Publication Publication Date Title
KR860001793A (ko) 벤즈 이미다졸 유도체의 제조방법
KR870003998A (ko) 퀴나졸린 유도체류의 제조방법
KR860002496A (ko) 카보닐 화합물의 제조방법
KR850006187A (ko) 신규 히달토인(Hydantoin) 유도체의 제조방법
KR840003260A (ko) [(3-아미노-3-카르복시)-프로필-1]포스핀산 유도체의 제조법
KR830010072A (ko) 아미디노 피페리딘 유도체의 제조방법
KR850005845A (ko) 7-아미노-3-치환된-메틸-3-세펨-4-카복실산 및 그의 저급 알킬실릴 유도체의 제조방법
SE7509271L (sv) Sett att framstella kinoxalin- och kinazolinderivat
KR830002716A (ko) 구아니딘 화합물의 제조방법
KR840000534A (ko) 디히드로피리딘 화합물류의 제조방법
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR850002459A (ko) 디히드록시벤즈아미드 유도체 및 그 제조방법
KR850001906A (ko) 치환된 페닐설포닐 구아니딘 및 그의 중간체의 제조방법
KR840001555A (ko) 치환된 2-페닐-2-(피리딜욕시)-에틸아민과 그의 등 배전자화합물 및 그들의 산부가염을 제조하는 방법
KR840004076A (ko) 티오메틸 파리딘 유도체의 제조방법
KR830005191A (ko) 푸란유도체의 제조방법
GB1508153A (en) 1,2,4-triazolyl-(1)derivatives a process for their preparation and their use as optical brighteners
KR830005225A (ko) 데오필린의 피페라진 유도체의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
US3974193A (en) 16-Fluoro prostaglandin B2 analogs
KR850007247A (ko) 바이페닐릴설포닐 우레아의 제조방법
US3974190A (en) 16-Fluoro prostaglandin A1 analogs
US3974189A (en) 16-Fluoro prostaglandin E2 analogs
US3974192A (en) 16-Fluoro prostaglandin B1 analogs